Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzo Biochem Inc (NYSE:ENZ)

2.87
Delayed Data
As of Aug 28
 +0.03 / +1.06%
Today’s Change
2.26
Today|||52-Week Range
6.13
-35.36%
Year-to-Date
No recent news for Enzo Biochem Inc.

Today’s Trading

Previous close2.84
Today’s open2.83
Day’s range2.82 - 2.96
Volume50,250
Average volume (3 months)202,762
Market cap$132.2M
Dividend yield--
Data as of 4:02pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)-30.43%
Earnings growth (next 5 years)--
Revenue growth (last year)+2.39%
P/E ratioNM
Price/Sales2.13
Price/Book3.44

Competitors

 Today’s
change
Today’s
% change
CDXSCodexis Inc+0.19+5.26%
QLTIQLT Inc+0.03+0.87%
BCLIBrainstorm Cell Ther...+0.14+4.83%
PBMDPrima BioMed Ltd+0.05+4.06%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateOctober 13, 2015
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$95.9M
Annual profit (last year)-$10.0M
Net profit margin-10.40%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive Officer &
Secretary
Elazar Rabbani
President, CFO, Treasurer, Director &
CAO
Barry W. Weiner
Corporate headquarters
New York, New York

Forecasts

Partner Offers